Severity
Moderate
FDA Devices recall · Reported April 13, 2022
Due to failure of microbial testing for total aerobic microbial count (TAMC).
Sa3, LLC recalled Silatrix Oral Gel Polymerized Sucralfate Gel 10% (1 gm/10 gm - a moderate-severity action.
Silatrix Oral Gel Polymerized Sucralfate Gel 10% (1 gm/10 gm was recalled by Sa3, LLC in April 13, 2022. Reason: Due to failure of microbial testing for total aerobic microbial count (TAMC).. Check the official notice for the remedy. Verify recall #Z-0856-2022 with the FDA Devices before acting.
The recall
Sa3, LLC issued this moderate-severity FDA Devices recall-Due to failure of microbial testing for total aerobic microbial count (TAMC)..
Sourced from official FDA Devices enforcement records. Verify recall #Z-0856-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-0856-2022) was formally reported on April 13, 2022, with the manufacturer initiating the action on February 21, 2022. It is classified under Moderate severity (Class II), with a current status of Terminated. Sa3, LLC is listed as the recalling firm, operating out of Los Angeles, CA. Federal records list the affected scope as 156 units.
The documented reason for this recall is: Due to failure of microbial testing for total aerobic microbial count (TAMC). Distribution data in the federal record shows the product reached: U.S. Nationwide distribution in the states of CA, FL and GA.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,861 medical devices recalls on record
Of 88,001 recalls with an agency hazard classification, 19,020 are high severity, 64,468 moderate, and 4,513 low. A further 16,157 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
156 units
Related Recalls
6
6 from same agency
Silatrix Oral Gel Polymerized Sucralfate Gel 10% (1 gm/10 gm
Due to failure of microbial testing for total aerobic microbial count (TAMC).
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-0856-2022 |
| Date reported | April 13, 2022 |
| Date initiated | February 21, 2022 |
| Recalling firm | Sa3, LLC |
| Firm location | Los Angeles, CA |
| Affected scope | 156 units |
| Distribution | U.S. Nationwide distribution in the states of CA, FL and GA. |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Boston Scientific Corporation · 2026-07-29
Boston Scientific Corporation · 2026-07-29
AVID Medical, Inc. · 2026-07-29
Penumbra, Inc. · 2026-07-29
Alphatec Spine, Inc. · 2026-07-29
Compare this recall with FARADRIVE STEERABLE SHEATH CLEAR, used to facilitate access… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported April 13, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.